Skip to main content
. 2019 Oct 27;53(1):e12701. doi: 10.1111/cpr.12701

Figure 5.

Figure 5

A, Western blot analysis of NLRP3 pathway activation after aconitine incubation for 24 h with or without the NLRP3 inhibitor MCC950; B, The subcellular location of NLRP3 and ASC used to detect NLRP3 inflammasome formation after aconitine incubation for 24 h with or without MCC950, scale bar: 6 μm